San Raffaele Hospital — Clinical Trial Site

37 Registered trials

18 Currently recruiting

Organisation

San Raffaele Hospital

Location

Milan, Italy

Identifier

ORG-100029986

Address

Via Olgettina 58, 20132, Italy

Departments

Anestesia e Rianimazione del distretto testa-collo
Arrhythmology and Electrophysiology
cardiology
Centro Scienze Natalità
Colorectal surgery Unit
Department Gastroenterology and Digestive Endoscopy
Department of Oncology
Ginecologia Ostetricia
Gynecology and Obstetrics Department
Immunoematologia Pediatrica
Infectious Diseases
Medical Oncology
Medicine and Diabetes Unit
Metabolic and Clinical Trial Unit
Neurology
Neuromuscular Repair Unit
Oncohematology
Oncologia Medica
Oncology
Orthopaedic and Trauma Unit
Paediatric hematology & Oncology
Paediatrics
Pediatric Immunohematology Unit
Radiotherapy Unit
Strategic Research Program on Chronic Lymphocytic Leukemia, Division of Experimental Oncology
Strategic Research Program on CLL
U.O. Immunoematologia Pediatrica
U.O. Pediatric Immunohematology
Unit of Infectious Diseases
Unità Operativa di Oculistica
UO Oncologia
UOC Oncologia

Clinical trials at this site (37)

Search interface

Clinical trial to evaluate safety and effectiveness of APL-101 for the treatment of advanced MET expressing solid tumors, including Non-Smal… Recruiting

2024-514542-37-00 Select advanced solid tumors and Non-Small Cell Lung Ca 9 2020-08-13
Comparison of continuing intravenous antibiotic therapy with switching to oral antibiotics in clinically stable patients with blood infectio… Ended

2024-517308-13-00 Gram-negative bacteraemia 6 2025-12-10
A Phase 3 Study Comparing BMS-986365 versus Investigator’s Choice of Therapy in Participants with Metastatic Castration-resistant Prostate C… Ended

2024-517422-25-00 Metastatic Castration-resistant Prostate Cancer (mCRPC) 5 2025-05-22
Single arm phase II study of ctDNA-guided encorafenib plus cetuximab retreatment in patients with BRAF V600E mutated mCRC. BRICKET study Ended

2023-509088-26-00 Metastatic colorectal cancer 4 2024-07-22
Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell… Ended

2023-503594-38-00 Select B-Cell malignancies. 1 2024-07-15
Evaluating efficacy and safety of switching a boosted protease inhibitor to fostemsavir in PLWH with limited therapeutic options (FOST Switc… Ended

2023-504192-25-00 HIV-1 6 2024-06-05
A Phase 1/2, Open-Label, Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Intrav… Ended

2023-506737-30-00 Duchenne Muscular Dystrophy 7 2024-03-08
A Placebo-Controlled Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With Atherosclerotic Cardiovascular Disease … Ended

2023-507795-51-00 atherosclerotic heart and blood vessel disease (the nar 5 2022-05-17
A prospective, observer-blind, randomized clinical trial to investigate and compare the clinical efficacy of Chloroprocaine 3% gel and Oxybu… Ended

2023-504477-21-01 male/female outpatients, aged 0-17 years scheduled to u 5 2024-05-14
Phase 2/3 Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer Ended

2022-502196-31-00 Advanced or Recurrent Endometrial Cancer 10 2023-08-21
A 12-month, randomized, single-blind, placebo-controlled exposure-response study of TCD601 (siplizumab) in new onset type 1 diabetes patient… Ended

2023-506837-31-00 New onset type I diabetes 4 2023-01-27
Study to evaluate the addition of an experimental drug, CC-90010, to the usual treatment of brain cancer after surgery Ended

2024-511171-15-00 Subjects with newly diagnosed WHO Grade IV glioblastoma 3 2020-07-06
Study to evaluate the efficacy and safety of a local anesthetic used in flat foot or inguinal hernia interventions at two different concentr… Ended

2024-518179-76-00 Calcagno stop and inguinal hernia repair 4 2019-03-11